Health Care & Life Sciences » Medical Equipment & Supplies | Ningbo MedicalSystem Biotechnology Co. Ltd.

Ningbo MedicalSystem Biotechnology Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
103,258.70
136,790.00
159,462.20
188,100.70
225,091.60
252,959.30
Depreciation, Depletion & Amortization
19,923.30
31,072.50
43,128.80
69,640.90
116,300.90
165,376.40
Other Funds
3,788.30
6,974.60
715,727.20
88,871.20
22,734.20
119,787.80
Funds from Operations
130,441.40
173,877.70
202,355.80
271,913.20
388,791.70
554,310.40
Changes in Working Capital
30,377.50
57,366.90
24,083.20
250,317.60
507,700.30
127,851.10
Net Operating Cash Flow
100,063.90
116,510.80
178,272.60
21,595.70
118,908.60
426,459.30
Capital Expenditures
72,608.80
73,634.50
92,274.50
292,590.20
405,299.70
Sale of Fixed Assets & Businesses
13.50
12,036.70
5,452.80
40,585.90
126,158.80
Purchase/Sale of Investments
-
41,433.80
287,186.20
320,132.40
31,956.00
Net Investing Cash Flow
72,006.30
91,373.20
410,214.80
696,533.30
306,896.50
Cash Dividends Paid - Total
-
30,000.00
-
34,002.00
20,857.60
Issuance/Reduction of Debt, Net
11,000.00
22,769.60
100,769.60
377,126.10
618,060.70
Net Financing Cash Flow
7,211.70
14,205.00
614,957.60
431,995.30
557,361.40
Net Change in Cash
35,269.30
10,949.00
384,069.60
239,135.10
127,458.50
Free Cash Flow
27,455.10
42,876.30
85,998.10
270,994.50
524,208.30
Deferred Taxes & Investment Tax Credit
896.20
1,192.80
2,618.80
6,688.80
7,472.10
16,186.90
Net Assets from Acquisitions
-
-
21,739.30
119,073.10
4,970.40
Other Sources
589.00
11,658.50
22,831.60
10,076.50
9,544.20
Change in Capital Stock
-
-
-
-
17,107.50
Exchange Rate Effect
-
16.30
1,054.10
3,807.20
4,097.80
Other Uses
-
-
37,299.20
15,400.00
373.40

About Ningbo MedicalSystem Biotechnology Co.

View Profile
Address
No.299 Qimingnan Road
Ningbo Zhejiang 315104
China
Employees -
Website http://www.nb-medicalsystem.com
Updated 07/08/2019
MedicalSystem Biotechnology Co., Ltd. engages in the research, development and manufacturing of bio-tech pharmaceutical products. Its activity includes the provision of medical diagnostics and consultation services. Its products include in-vitro biochemical diagnostic reagents and instruments.